Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation

Brunet, 2016, Barcelona consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation, Ther. Drug Monit., 38, S1, 10.1097/FTD.0000000000000287 Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U. S. A., 105, 10513, 10.1073/pnas.0804549105 Pekarsky, 2015, Role of miR-15/16 in CLL, Cell Death Differ., 22, 6, 10.1038/cdd.2014.87 Finnerty, 2010, The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases, J. Mol. Biol., 402, 491, 10.1016/j.jmb.2010.07.051 Li, 2015, Genome-wide analysis of microRNA and mRNA expression signatures in cancer, Acta Pharmacol. Sin., 36, 1200, 10.1038/aps.2015.67 Keller, 2009, Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls, PLoS One, 4, 10.1371/journal.pone.0007440 Trionfini, 2015, MicroRNAs in kidney physiology and disease, Nat. Rev. Nephrol., 11, 23, 10.1038/nrneph.2014.202 Noureddine, 2013, MicroRNAs and polycystic kidney disease, Drug Discov. Today Dis. Model., 10, 10.1016/j.ddmod.2013.10.001 Lorenzen, 2011, MicroRNAs as mediators and therapeutic targets in chronic kidney disease, Nat. Rev. Nephrol., 7, 286, 10.1038/nrneph.2011.26 Chafin, 2013, MicroRNAs implicated in the immunopathogenesis of lupus nephritis, Clin. Dev. Immunol., 2013, 430239, 10.1155/2013/430239 Li, 2014, MicroRNAs in diabetic kidney disease, Int. J. Endocrinol., 2014, 593956, 10.1155/2014/593956 Wu, 2014, The role of microRNAs in diabetic nephropathy, J. Diab. Res., 2014, 920134 Vitalone, 2015, Transcriptional perturbations in graft rejection, Transplantation, 99, 1882, 10.1097/TP.0000000000000809 Soltaninejad, 2015, Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection, Transpl. Immunol., 33, 1, 10.1016/j.trim.2015.05.002 Tao, 2015, Serum microRNA-99a helps detect acute rejection in renal transplantation, Transplant. Proc., 47, 1683, 10.1016/j.transproceed.2015.04.094 Betts, 2014, Examination of serum miRNA levels in kidney transplant recipients with acute rejection, Transplantation, 97, 10.1097/01.TP.0000441098.68212.de Lorenzen, 2011, Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients, Am. J. Transplant., 11, 2221, 10.1111/j.1600-6143.2011.03679.x Danger, 2013, Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection, PLoS One, 8, 10.1371/journal.pone.0060702 Ben-Dov, 2012, MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis, Transplantation, 94, 1086, 10.1097/TP.0b013e3182751efd Scian, 2011, MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA, Am. J. Transplant., 11, 2110, 10.1111/j.1600-6143.2011.03666.x Matz, 2016, Identification of T cell-mediated vascular rejection after kidney transplantation by the combined measurement of 5 specific microRNAs in blood, Transplantation, 100, 898, 10.1097/TP.0000000000000873 Lachmann, 2013, Luminex((R)) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion, Transfus. Med. Hemother., 40, 182, 10.1159/000351459 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc., 57, 289 Youden, 1950, Index for rating diagnostic tests, Cancer, 3, 32, 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 Pritchard, 2012, Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies, Cancer Prev. Res. (Phila.), 5, 492, 10.1158/1940-6207.CAPR-11-0370 Del Vescovo, 2014, MicroRNAs as lung cancer biomarkers, World J. Clin. Oncol., 5, 604, 10.5306/wjco.v5.i4.604 Anwar, 2015, MicroRNAs: emerging novel clinical biomarkers for hepatocellular carcinomas, J. Clin. Med., 4, 1631, 10.3390/jcm4081631 Ellinger, 2015, Epigenetic biomarkers in the blood of patients with urological malignancies, Expert. Rev. Mol. Diagn., 15, 505, 10.1586/14737159.2015.1019477 Ramezani, 2015, Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study, Eur. J. Clin. Investig., 45, 394, 10.1111/eci.12420 Wang, 2012, Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease, Braz. J. Med. Biol. Res., 45, 1308, 10.1590/S0100-879X2012007500165 Creemers, 2012, Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?, Circ. Res., 110, 483, 10.1161/CIRCRESAHA.111.247452 Linsley, 2007, Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression, Mol. Cell. Biol., 27, 2240, 10.1128/MCB.02005-06 Singh, 2015, MicroRNA-15b/16 enhances the induction of regulatory T cells by regulating the expression of Rictor and mTOR, J. Immunol., 195, 5667, 10.4049/jimmunol.1401875